USPTO serial 88660548
ALEMBIC
Reviewed by CopyMark Law Group
Status 603
- Filing date
- Status date
- Registration date
- —
- Examiner
- OPUTA, CHIOMA N
- Law office
- TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALEMBIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Albert H. Manwaring IV
Albert H. Manwaring IV MORRIS JAMES LLP500 DELAWARE AVENUE STE 1500WILMINGTON, DE 19801UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Generic prescription drugs, approved by the U.S. Food and Drug Administration, namely, prescription drugs in the nature of pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations, for the treatment of allergic conjunctivitis, Alzheimer's disease, anxiety, bacterial infections, depression, epilepsy, infection, inflammation and allergies, ulcers, bacterial conjunctivitis, bipolar disorder, bronchoconstriction, erectile dysfunction, fungal infection, glaucoma, herpes, hypercholesterolemia, hypertension, hyperuricemia, hypoparathyroidism, influenza A and B, Parkinson's disease/syndrome, insomnia, intraocular pressure, paralysis, amnesia, unconsciousness, high cholesterol, neuropathic pain, arthritic pain and inflammation, ocular infections, overactive bladder, postoperative inflammation, ocular pain, cough, inflammatory and pruritic manifestations, rheumatoid arthritis, seizure, panic disorder, sleep disorder, transfusional iron overload, and moderate to severe scalp psoriasis; all of the foregoing prescribed by a licensed medical doctor with the prescriptions filled by a retail pharmacy licensed to sell prescription drugs | ACTIVE | Jan 1, 1907 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 3, 2022 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| May 26, 2022 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| May 26, 2022 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Mar 11, 2022 | EXPA | EX PARTE APPEAL-REFUSAL AFFIRMED | — |
| Oct 14, 2021 | GNSN | NOTIFICATION OF EXAMINERS STATEMENT E-MAILED | — |
| Oct 14, 2021 | GNES | EXAMINERS STATEMENT E-MAILED | — |
| Oct 14, 2021 | CNES | EXAMINERS STATEMENT - COMPLETED | — |
| Aug 17, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Aug 16, 2021 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Jun 16, 2021 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jun 16, 2021 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jun 16, 2021 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Jun 16, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 16, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 16, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 16, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 9, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 9, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 9, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 9, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 28, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 6, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 6, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2021 | ALIE | ASSIGNED TO LIE | — |
| Mar 24, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 5, 2021 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Jan 5, 2021 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Jan 5, 2021 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Dec 1, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 1, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 1, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 29, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 12, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jul 1, 2020 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jul 1, 2020 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jul 1, 2020 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jun 30, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 17, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 17, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 17, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 20, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 27, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 27, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 22, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |